Browsing Tag
Biologics Manufacturing
384 posts
Jubilant To Invest $92 M in Injectables Mfg; Vibalogics, Selkirk Expand
By
The latest from CDMOs, CMOs, and suppliers featuring Jubilant HollisterStier, Vibalogics, Selkirk Pharma, VIVEbiotech, Gattefossé, Ori Biotech, Yourway, Olon, and Piramal. Biologics Manufacturing Vibalogics Initiates $50-M Expansion for Viral Vector…
Vectura in Proposed $1.3-Bn Buyout; Samsung Adds mRNA Mfg
By
The latest from CDMOs, CMOs, and suppliers featuring Vectura, Samsung Biologics, Lonza’s Bachthera, Avantor, Cytiva, Aceto, Danaher, Sharp, Stevanato Group, and others. Chemicals/Chemical API Manufacturing Aceto Acquires CDMO Cascade Chemistry…
Resilience To Get $164 M from Canadian Gov’t for Biomfg Site Expansion
By
Resilience, a recently launched manufacturing and technology company for biologics and advanced therapies, will receive a CAD 199.2-million ($164-million) investment from the Canadian government, to modernize and expand the biomanufacturing…
CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects
By
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Fujifilm Wako Pure Chemical, Chime Biologics, and Vectura Group. Chemicals/Chemical API Manufacturing Fujifilm Wako Pure Chemical Launches SARS-CoV-2 Mutation-Detection Kit…
Charles River To Acquire CDMO Vigene Biosciences in $350-M Deal
By
Charles River Laboratories, a Wilmington, Massachusetts-headquartered contract research organization, has agreed to acquire Vigene Biosciences, a Rockville, Maryland-based CDMO specializing in viral vectors, in a deal worth up to $350…
Carbogen Amcis, CordenPharma, Novasep, PHT, Cambrex, Catalent Expand
By
The latest from CDMOs, CMOs, and suppliers featuring Carbogen Amcis, CordenPharma, Novasep, PHT, Cambrex, Catalent, Aenova, Enteris BioPharma, and NJ Biopharmaceuticals. Chemicals/Chemical API Manufacturing Carbogen Amcis To Expand Swiss Site…
AMRI Expands; Richter–Helm Starts Construction of $84-M Biomfg Facility
By
The latest from CDMOs, CMOs, and suppliers featuring AMRI, Richter–Helm, and Cellares Corporation. Biologics Manufacturing Richter–Helm Starts Construction of $84-M Biomanufacturing Facility Richter–Helm, a biologics CDMO based in Hamburg, Germany,…